JOE
HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Journal of Endocrinology (1989) 123, 363-366    DOI: 10.1677/joe.0.1230363
© 1989 Society for Endocrinology

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Whitehouse, B. J.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Whitehouse, B. J.

Lipocortins, mediators of the anti-inflammatory actions of corticosteroids?

B. J. Whitehouse

It is exactly 40 years since the first dramatic (and almost totally unpredicted) report that cortisone inhibited inflammation and reduced the symptoms of arthritis (Hench, Kendall, Slocumb & Polley, 1949). Since then, the history of the use of glucocorticoids as anti-inflammatory agents has become almost a matter of common knowledge. First hailed as miracle drugs but then found to have very dangerous side-effects if used indiscriminately (Gaunt, 1974), it nevertheless remains true that glucocorticoids are still very widely prescribed since they can be used to suppress almost any type of inflammation. In view of this long history it is surprising that it is only recently there has been significant progress in the understanding of the cellular mechanisms by which glucocorticoids inhibit inflammation. Moreover, the information that has accumulated has had the unforeseen effect of drawing together several apparently unrelated fields of research, and in some ways it might seem to







HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1989 by the Society for Endocrinology.